OpenAlex
PricingAboutJobs
Log inGet started
Work

The development of an off-the-shelf CAR T-cell therapy co-targeting CD19 and CD38 for broad application in autoimmune disease

HTML

Year: 2025
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2025-5895
Authors: Mark Jelcic, Daniel Morales-Mantilla, John Reiser, Brian Groff, Alma Gutierrez, Rina Ngalame, Alan Williams, Carissa Dege, Shilpi Chandra, Spas Markov, Soheila Shirinbak, Bjoern Gaertner, Mochtar Pribadi, Karina Palomares, Loraine Campanati, Amanda Yzaguirre, Stephanie Kennedy, Angela Macia, Alison O'Connor, Bryan Hancock, Pei-Fang Tsai, Ramzey Abujarour, Tom Lee, Raedun Clarke, Karl-Johan Malmberg, Maksim Mamonkin, Bahram Valamehr, Vaneet Sandhu, Alex Garcia, Martin Hosking, John Goulding, Jode Goodridge
Institutions: Fate Therapeutics (United States), Oslo University Hospital, University of Oslo, Karolinska Institutet, Baylor College of Medicine
Language: English

Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4417023389
Cites:
Cited by:
Related to:
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms